{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:06:36Z","timestamp":1744153596280},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA024598","R01DA033862"],"award-info":[{"award-number":["R01DA024598","R01DA033862"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000117","TL1RR033172"],"award-info":[{"award-number":["UL1TR000117","TL1RR033172"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cct.2014.12.015","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T19:45:18Z","timestamp":1419882318000},"page":"9-16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment"],"prefix":"10.1016","volume":"41","author":[{"given":"April M.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin B.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan A.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Havens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.cct.2014.12.015_bb0005","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cct.2014.12.015_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cct.2014.12.015_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2012.09.011","article-title":"The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States","volume":"17","author":"Ward","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"19","key":"10.1016\/j.cct.2014.12.015_bb0020","first-page":"517","article-title":"Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users\u2014New York, November 2004\u2013April 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.cct.2014.12.015_bb0025","first-page":"537","article-title":"Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002\u20132009","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.cct.2014.12.015_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archinternmed.2010.511","article-title":"Incidence and transmission patterns of acute hepatitis C in the United States, 1982\u20132006","volume":"171","author":"Williams","year":"2011","journal-title":"Arch Intern Med"},{"issue":"RR-11","key":"10.1016\/j.cct.2014.12.015_bb0035","first-page":"1","article-title":"Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"issue":"14","key":"10.1016\/j.cct.2014.12.015_bb0040","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/QAD.0b013e3282ef7701","article-title":"Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough","volume":"21","author":"Page-Shafer","year":"2007","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.cct.2014.12.015_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.epidem.2008.10.002","article-title":"Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users","volume":"1","author":"Hahn","year":"2009","journal-title":"Epidemics"},{"issue":"13","key":"10.1016\/j.cct.2014.12.015_bb0050","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.vaccine.2004.09.023","article-title":"Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada","volume":"23","author":"Krahn","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cct.2014.12.015_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0950268808000873","article-title":"Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy","volume":"137","author":"Massad","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.cct.2014.12.015_bb0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus","volume":"54","author":"Torresi","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.cct.2014.12.015_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.micpath.2013.02.005","article-title":"Hepatitis C virus vaccines\u2014progress and perspectives","volume":"58","author":"Fauvelle","year":"2013","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/j.cct.2014.12.015_bb0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14712598.2013.791277","article-title":"Ever closer to a prophylactic vaccine for HCV","volume":"13","author":"Swadling","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.cct.2014.12.015_bb0315","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/emi.2013.79","article-title":"Progress towards a hepatitis C virus vaccine","volume":"2","author":"Law","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2014.12.015_bb0080","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/cid\/cit329","article-title":"Hepatitis C virus vaccines among people who inject drugs","volume":"57","author":"Cox","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"42","key":"10.1016\/j.cct.2014.12.015_bb0085","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2014.07.091","article-title":"Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study","volume":"32","author":"White","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cct.2014.12.015_bb0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/591699","article-title":"Intranasal transmission of hepatitis C virus: virological and clinical evidence","volume":"47","author":"Aaron","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cct.2014.12.015_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1478-3231.2008.01688.x","article-title":"High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack","volume":"28","author":"Macias","year":"2008","journal-title":"Liver Int"},{"issue":"45","key":"10.1016\/j.cct.2014.12.015_bb0100","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1016\/j.vaccine.2010.08.085","article-title":"Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities","volume":"28","author":"Maher","year":"2010","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.cct.2014.12.015_bb0105","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1016\/j.vaccine.2010.07.006","article-title":"Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?","volume":"28","author":"Levy","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.cct.2014.12.015_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.10.009","article-title":"Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs","volume":"123","author":"Park","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"32","key":"10.1016\/j.cct.2014.12.015_bb0115","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1016\/j.vaccine.2010.05.064","article-title":"\u201cFitness for duty\u201d: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs","volume":"28","author":"Treloar","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cct.2014.12.015_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugpo.2009.04.004","article-title":"Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs","volume":"21","author":"Maher","year":"2010","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.cct.2014.12.015_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cct.2009.04.002","article-title":"Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study","volume":"30","author":"Doab","year":"2009","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"10.1016\/j.cct.2014.12.015_bb0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QAI.0b013e3181acff91","article-title":"Using social networks to recruit an HIV vaccine preparedness cohort","volume":"52","author":"Valente","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.cct.2014.12.015_bb0135","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.2105\/AJPH.2012.300874","article-title":"Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users","volume":"103","author":"Havens","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.cct.2014.12.015_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/003335491012500116","article-title":"Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients","volume":"125","author":"Christian","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/j.cct.2014.12.015_bb0145","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.cct.2014.12.015_bb0320","series-title":"The College on Problems of Drug Dependence Annual Meeting; June 2014; San Juan, Puerto Rico","article-title":"Injection drug use and other risk behaviors among rural prescription opioid users","author":"Havens","year":"2014"},{"issue":"42","key":"10.1016\/j.cct.2014.12.015_bb0155","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2014.07.091","article-title":"Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study","volume":"32","author":"White","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cct.2014.12.015_bb0160","author":"Appalachian Regional Commission"},{"key":"10.1016\/j.cct.2014.12.015_bb0165","series-title":"An analysis of disparities in health status and access to health care in the Appalachian Region","author":"Halverson","year":"2004"},{"key":"10.1016\/j.cct.2014.12.015_bb0175","author":"Appalachian Regional Commission"},{"key":"10.1016\/j.cct.2014.12.015_bb0180","author":"Kentucky Legislative Research Commission"},{"key":"10.1016\/j.cct.2014.12.015_bb0185","author":"Kentucky Legislative Research Commission"},{"key":"10.1016\/j.cct.2014.12.015_bb0190","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10461-014-0797-9","article-title":"Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis","volume":"18","author":"Young","year":"2014","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.cct.2014.12.015_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3343\/alm.2013.33.3.184","article-title":"Performance evaluation of the OraQuick hepatitis C virus rapid antibody test","volume":"33","author":"Cha","year":"2013","journal-title":"Ann Lab Med"},{"issue":"7","key":"10.1016\/j.cct.2014.12.015_bb0200","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s10461-012-0371-2","article-title":"Network structure and the risk for HIV transmission among rural drug users","volume":"17","author":"Young","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.cct.2014.12.015_bb0325","series-title":"Ucinet for Windows: software for social network analysis","author":"Borgatti","year":"2002"},{"key":"10.1016\/j.cct.2014.12.015_bb0330","series-title":"Netdraw network visualization","author":"Borgatti","year":"2002"},{"issue":"6","key":"10.1016\/j.cct.2014.12.015_bb0215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1746-1561.2011.00595.x","article-title":"Adolescent attitudes toward influenza vaccination and vaccine uptake in a school-based influenza vaccination intervention: a mediation analysis","volume":"81","author":"Painter","year":"2011","journal-title":"J Sch Health"},{"issue":"3","key":"10.1016\/j.cct.2014.12.015_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017713","article-title":"Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study","volume":"6","author":"Liao","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cct.2014.12.015_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/07448481.2011.580028","article-title":"Human papillomavirus vaccine intent and uptake among female college students","volume":"60","author":"Patel","year":"2012","journal-title":"J Am Coll Health"},{"key":"10.1016\/j.cct.2014.12.015_bb0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/209170","article-title":"The theory of reasoned action: a meta-analysis of past research with recommendations for modifications and future research","volume":"15","author":"Sheppard","year":"1988","journal-title":"J Consum Res"},{"issue":"29","key":"10.1016\/j.cct.2014.12.015_bb0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1348\/014466601164939","article-title":"Efficacy of the theory of planned behavior: a meta-analytic review","volume":"40","author":"Armitage","year":"2001","journal-title":"Br J Soc Psychol"},{"issue":"4","key":"10.1016\/j.cct.2014.12.015_bb0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.2044-8309.1994.tb01037.x","article-title":"The time interval in the intention behaviour relationship: meta analysis","volume":"33","author":"Randall","year":"1994","journal-title":"Br J Soc Psychol"},{"issue":"6","key":"10.1016\/j.cct.2014.12.015_bb0245","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/157016212802429811","article-title":"Using psychological principles to narrow the intention\u2013behavior gap and increase participation in HIV vaccine trials","volume":"10","author":"Poole","year":"2012","journal-title":"Curr HIV Res"},{"issue":"3","key":"10.1016\/j.cct.2014.12.015_bb0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2008.12.007","article-title":"Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)","volume":"101","author":"Evans","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.cct.2014.12.015_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988\u20132000","volume":"83","author":"Shah","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cct.2014.12.015_bb0340","series-title":"SAS\/STAT 93 user's guide","article-title":"The GLIMMIX Procedure","author":"SAS Institute","year":"2011"},{"issue":"4","key":"10.1016\/j.cct.2014.12.015_bb0265","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/biomet\/80.4.791","article-title":"Laplace's approximation for nonlinear mixed models","volume":"80","author":"Wolfinger","year":"1993","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.cct.2014.12.015_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1525\/sp.2002.49.1.11","article-title":"Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations","volume":"49","author":"Heckathorn","year":"2002","journal-title":"Soc Probl"},{"key":"10.1016\/j.cct.2014.12.015_bb0275","series-title":"Respondent-driven sampling analysis tool (RDSAT) version 7.1","author":"Volz","year":"2012"},{"key":"10.1016\/j.cct.2014.12.015_bb0280","series-title":"Collinearity macro (SAS) (contact David Kleinbaum at dkleinb@sph.emory.edu)","author":"Zack","year":"2011"},{"key":"10.1016\/j.cct.2014.12.015_bb0285","series-title":"Logistic regression: a self-learning text","author":"Kleinbaum","year":"2010"},{"issue":"537","key":"10.1016\/j.cct.2014.12.015_bb0290","article-title":"HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study","volume":"14","author":"Young","year":"2014","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.cct.2014.12.015_bb0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1525\/jer.2010.5.2.65","article-title":"Enhancing HIV, vaccine trial consent preparedness among street drug users","volume":"5","author":"Fisher","year":"2010","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"4","key":"10.1016\/j.cct.2014.12.015_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/dar.12000","article-title":"Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs","volume":"32","author":"White","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.cct.2014.12.015_bb0305","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.cct.2014.12.015_bb0310","author":"Foundation for AIDS Research"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T22:24:01Z","timestamp":1566167041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714414002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":61,"alternative-id":["S1551714414002006"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2014.12.015","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2014.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}